Viemed Healthcare, Inc. (NASDAQ:VMD) is the best undervalued stock to buy now under $20.
Viemed Healthcare, Inc. (NASDAQ:VMD) might not be on every investor’s radar, but it absolutely deserves a spot on the list of undervalued gems under $20. Specializing in home based medical equipment and post acute respiratory care services, Viemed delivers crucial support to patients with conditions like COPD through non invasive ventilation, percussion vests, and more.
From a fundamentals perspective, the stock checks all the right boxes. As of June 13, it trades with a forward P/E of just 13.84, suggesting the market hasn’t fully priced in its growth potential. It also boasts an impressive PEG ratio of 0.73, indicating growth at a bargain, and a debt to equity ratio of only 0.05, highlighting a strong balance sheet with minimal financial risk.
So, what’s driving the optimism? Viemed Healthcare, Inc. (NASDAQ:VMD) just posted an impressive Q1 2025, outperforming expectations and tightening its full year guidance upward. Its ventilation segment, which makes up 54% of revenue, grew 10% year over year, with new patient starts up 9% sequentially. Even more impressive, this marked the 16th consecutive quarter of vent patient growth, thanks to a revamped sales strategy rolled out last year.
But Viemed isn’t just a one trick pony. The sleep therapy segment surged 46% year over year, while the resupply and staffing services also delivered strong gains. The company’s diversified approach, targeting underserved populations with personalized in home care, is exactly what the evolving U.S. healthcare landscape is moving toward.
On the regulatory front, Viemed Healthcare, Inc. (NASDAQ:VMD) stands out by actively engaging with policymakers to shape smarter, more data driven healthcare rules. Recent legislative wins in Arkansas and other states support broader access to the company’s core therapies, validating its model and future prospects.
To top it off, Viemed Healthcare, Inc. (NASDAQ:VMD) recently acquired Lehan’s Medical Equipment, giving it a strategic foothold in the Chicago market and new growth channels in women’s health and sleep care.
In short, Viemed Healthcare, Inc. (NASDAQ:VMD) combines financial strength, steady growth, and regulatory momentum, all wrapped in an undervalued stock under $20. For long term investors looking for resilience and upside, VMD looks like a smart bet.
Check the Complete list here: 7 Best Undervalued Stocks to Buy Now Under $20